Myeloproliferative Neoplasms (Online CE Course)

(based on 369 customer ratings)

Author: Leah Coppolino, MPH, CLS(NCA), MT(ASCP)
Reviewer: Rebecca J. Laudicina, PhD, MLS(ASCP)CM

See all available courses »

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 1 hour(s)
Course number 578-011-17, approved through 2/28/2019
Course number 20-547797, approved through 9/1/2018

Objectives

  • Describe the 2008 World Health Organization classification system for myeloproliferative neoplasms (MPNs).
  • Compare and contrast the types of MPNs based upon etiology and patient symptoms.
  • Discuss the hematologic, cytogenetic, and other laboratory features associated with specific MPNs.
  • List common treatment options.

Customer Ratings

(based on 369 customer ratings)

Course Outline

Click on the links below to preview selected pages from this course.
  • Myeloproliferative Neoplasms
    • Chronic Myeloid Leukemia
    • Chronic Neutrophilic Leukemia
      • Chronic Neutrophilic Leukemia (CNL)
      • Chronic Neutrophilic Leukemia (CNL), continued
    • Hypereosinophilic Syndrome/Chronic Eosinophilic Leukemia
      • Hypereosinophilic Syndrome (HES)
      • Chronic Eosinophilic Leukemia (CEL)
      • What causes the characteristic heart and/or lung damage frequently demonstrated in patients with chronic eosinophilic leukemia?
    • Essential Thrombocythemia
    • Primary Myelofibrosis
      • Primary Myelofibrosis (PMF)
      • Diagnosis of Primary Myelofibrosis (PMF)
      • Diagnosis of Primary Myelofibrosis: World Health Organization (WHO) Criteria
      • Which of the following red blood cell morphologic features is associated with primary myelofibrosis?
    • Polycythemia Vera
      • Polycythemia Vera (PV)
      • Diagnosis of Polycythemia Vera (PV)
      • Treatment of Polycythemia Vera
      • Which type of anemia can be caused by the common treatment for polycythemia vera, which is used to manage patient symptoms?
    • Myeloproliferative Neoplasm, Unclassifiable (MPN-u)
      • Myeloproliferative Neoplasms, Unclassifiable (MPD-u)
  • Summary
      • Table: Laboratory Findings Associated with Myeloproliferative Neoplasms (MPNs)
  • References
      • References

Additional Information

Level of instruction: Intermediate

Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
 
Author information: Leah Coppolino, MPH, CLS(NCA), MT(ASCP) is the Director of Education and Outreach in the Department of Pathology and Laboratory Medicine at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.
 
Reviewer information: Rebecca J. Laudicina, PhD, MLS(ASCP)CM is Professor Emeritus in the Division of Clinical Laboratory Science at The University of North Carolina at Chapel Hill’s School of Medicine. She obtained a Master of Education and PhD in Educational Psychology from Temple University. She is the author of numerous hematology-related publications.

Keywords

These are the most common topics and keywords covered in Myeloproliferative Neoplasms:

cells asymptomatic neoplastic exon red blood cell heart hematopoietic neoplasmmost lung eosinophils ratio losseasy hepatosplenomegaly morphology chromosome eosinophil chemotherapy disorders lymphocytic recommends myeloid cure erythropoietin diseases cavity clonal biopsy phosphatase bone marrow diagnose thrombopoietin erythrocytosis platelets lactate lineage neoplasms eosinophilic unsuccessful criterion somatic interferon karyotypic neutrophilia reactive dysplasia hematopoiesis abnormality syndrome mpns blood abnormal numbers wbcs translocation myeloproliferative mast cell hypercellular dehydrogenase myelodysplastic myeloiderythroid leukocyte clones myelofibrosis monocytes acute neutrophils fibrotic aspiration megakaryocytic abl1 epinephrine disease basophils adenosine fibrosis phlebotomy over-proliferation subtype low-dose myelofibrosisfibroblastpolycythemia progenitor treatment diphosphate extramedullary transformation cutaneous malignant turnover lymphoblastic alkaline anemia cancer precursors aggregation poikilocytosis transformational clumps red blood cells answers dysplastic cellularity diagnostic thrombocytosis breathunexplained leukemia iron wright-stained linechronic hydroxyurea clinical hematocrit indolent megakaryocyte prefibrotic polycythemia lplatelet cobalamin thrombocythemia cellular prothrombin deficiency mast cells jak2 mastocytosis erythroid stem abnormalities megakaryocytes laboratory conditions diagnosis hypereosinophilic thrombopoeitinusually reticulin philadelphia tyrosine neoplasm granulocytic serum bleedingpetechiaenight leukemic includenormal mutation gene clonality chromosomes mpn-u lhemoglobin granulocytes hemoglobin immature eosinophilia myelogenous splenomegaly hypercellularity evaluation kinase protocols tryptase platelet thrombotic unclassifiable hematologic aspirate fibrous erythrocyte neutrophilic cancertopics cytogenetic erythrocytic calreticulin peripheral blood smear symptoms health thromboplastin
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 101 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart


BM biopsy megakayocytes abnormal


Chronic Myelogenous Leukemia. Peripheral Blood Smear.
Image Credit: Paulo Henrique Orlandi Mourao


Bacterial infection, many neutrophils


CML


CMLspread


pt16-basophil


therapeutic phlebotomy from ITXMdiagnostics website with permission 8-2014 LC